Transforming activity of retroviral genomes encoding Gag-axl fusion proteins

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 8089-8097

  Zhang, Qing Kevin ^a   Boast, Sharon ^a   De Los Santos, Kenia ^a   Begemann, Martin ^a   Goff, Stephen P ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HYBRID PROTEIN; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; MALIGNANT TRANSFORMATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS TRANSFORMATION;

EID: 0029826881     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.8089-8097.1996     Document Type: Article

References (52)

1. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (London) 318:533-538.
2. Alexander, W. S., J. M. Adams, and S. Cory. 1989. Oncogene cooperation in lymphocyte transformation: malignant conversion of Eμ-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl. Mol. Cell. Biol. 9:67-73.
3. Ålin, K., and S. P. Goff. 1996. Mutational analysis of interactions between the Gag precursor proteins of murine leukemia viruses. Virology 216:418-424.
4. Anderson, S. J., M. A. Gonda, C. W. Rettenmier, and C. L. Sheer. 1984. Subcellular localization of glycoproteins encoded by the viral oncogene v-fms. J. Virol. 51:730-741.
5. Bassin, M., and M. L. Privalsky. 1987. Transmembrane domain of the AEV erb B oncogene protein is not required for partial manifestation of the transformed phenotype. Virology 159:20-30.
6. Bellacosa, A., J. R. Testa, S. P. Staal, and P. N. Tsichlis. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274-277.
7. Berlioz, C., and J. Darlix. 1995. An internal ribosomal entry mechanism promotes translation of murine leukemia virus Gag polyprotein precursors. J. Virol. 69:2214-2222.
8. Berns, A. 1991. Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes. J. Cell. Biochem. 47:130-135.
9. Colicelli, J., and S. P. Goff. 1988. Sequence and spacing requirements of a retrovirus integration site. J. Mol. Biol. 199:47-59.
10. Coulier, F., D. Martin-Zanca, M. Ernst, and M. Barbacid. 1989. Mechanism of activation of the human trk oncogene. Mol. Cell. Biol. 9:15-23.
11. Downward, J., Y. Yarden, G. Mayes, G. Scrace, N. Totty, A. Stockwell, A. Ullrich, J. Schlessinger, and M. D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequence. Nature (London) 307:521-527.
12. Fantl, W. J., D. E. Johnson, and L. T. Williams. 1993. Signaling by receptor tyrosine kinases. Annu. Rev. Biochem. 62:453-481.
13. Faust, M., C. Ebensperger, A. S. Shulz, et al. 1992. The murine ufo receptor: molecular cloning, chromosomal localization and in situ expression analysis. Oncogene 7:1287-1293.
14. Fridell, Y. W., Y. Jin, L. A. Quilliam, A. Burchert, P. McClosky, G. Spizz, B. Varnum, C. Der, and E. T. Liu. 1996. Differential activation of the Ras/ extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol. Cell. Biol. 16:135-145.
15. Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. Fusion of PDGF receptor B to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5:12) chromosomal translocation. Cell 77:307-316.
16. Greco, A., M. A. Pierotti, I. Bongarzone, S. Pagliardi, C. Lanzi, and G. Delia Porta. 1992. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene 7:237-242.
17. Harris, A. W., C. A. Pinkert, M. Crawford, W. Y. Langdon, R. L. Brinster, and J. M. Adams. 1988. The Eu-myc transgenic mouse. J. Exp. Med. 167: 353-371.
18. Jassen, J. W. G., A. S. Schulz, A. C. M. Steenvoorden, M. Schmidberger, S. Strehl, P. F. Ambras, and C. R. Bartram. 1991. A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene 6:2113-2120.
19. Jia, R., B. J. Mayer, T. Hanafusa, and H. Hanafusa. 1992. A Novel oncogene, v-ryk, encoding a truncated receptor tyrosine kinase is transduced into the RPL30 virus without loss of viral sequences. J. Virol. 66:5975-5987.
20. Langdon, W, Y., A. W. Harris, and S. Cory. 1989. Acceleration of B-lymphoid tumorigenesis in Eu-myc transgenic mice by v-H-ras and v-raf but not v-abl. Oncogene Res. 4:253-258.
21. Laio, P. A., and P. N. Tsichlis. 1990. Biology and pathogenesis of retroviruses. Semin. Oncol. 17:269-294.
22. Manger, R., L. Najita. E. J. Nichols, S. Hakomori, and L. Rohrschneider. 1984, Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp140fms). Cell 39:327-337.
23. Mark, G. E., and U. R. Rapp. 1984. Primary structure of v-raf: relatedness to the src family of oncogenes. Science 224:285-289.
24. McCutchan, J. H., and J. S. Pagano. 1968. Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J. Natl. Cancer Inst. 41:351-357.
25. McWhirter, J. R., D. L. Galasso, and J. Y. J. Wang. 1993. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13:7587-7595.
26. Neubauer, A., A. Fiebeler, D. K. Graham, J. P. O'Bryan, C. A. Schmidt, P. Barckow, S. Serke, W. Siegert, H. R. Snodgrass, D. Huhn, and E. T. Liu. 1994. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood 84:1931-1941.
27. Nichols, E. J., R. Manger, S. Hakomori, A. Herscovlcs, and L. R. Rohrschneider. 1985. Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression. Mol. Cell. Biol. 5:3467-3475.
28. O'Bryan, J. P., R. A. Frye, P. C. Cogswell, A. Neubauer, B. Kiteh, C. Prokop, R. Espinosa III, M. M. Le Beau, H. S. Earp, and E. T. Liu. 1991. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell. Biol. 11:5016-5031.
29. Ohashi, K., K. Nagata, J. Toshima, T. Nakano, H. Arita. H. Tsuda, K. Suzuki, and K. Mizuno. 1995. Stimulation of Sky receptor tyrosine kinase by the product of growth arrest-specific gene 6. J. Biol. Chem. 270:22681-22684.
30. Poon, B., D. Dixon, L. Ellis, R. A. Roth, W. J. Rutter, and L. H. Wang. 1991. Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras. Proc. Natl. Acad. Sci. USA 88:877-881.
31. Privalsky, M. L., and J. M. Bishop. 1984. Subcellular localization of the v-erb-B protein, the product of a transforming gene of avian erytbroblastosis virus. Virology 135:356-368.
32. Piywes, R., J. Hoag. N. Rosenberg, and D. Baltimore. 1985. Protein stability explains the Gag requirement for translation of lymphoid cells by Abelson murine leukemia virus. J. Virol. 54:123-132.
33. Reddy, E. P., M. J. Smith, and A. Srinivasan. 1983. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other one gene products with tyrosine-specific kinase activity. Proc. Natl. Acad. Sci. USA 80:3623-3627.
34. Rettenmier, C. W., M. F. Roussel, C. O. Quinn, G. R. Kitchingman, A. T. Look, and C. J. Sherr. 1985. Transmembrane orientation of glycoproteins encoded by the v-fms oncogene. Cell 40:971-981.
35. Rodrigues, G. A., and M, Park. 1993. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol. Cell. Biol. 13:6711-6722.
36. Schlcssinger, J., and A. Ullrich. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391.
37. Schmidt, J. A., H. Beug, and M. J. Hayman. 1985. Effects of inhibitors of glycoprotein processing on the synthesis and biological activity of the erb B oncogene. EMBO J. 4:105-112.
38. Shinkai, Y., G. Rathbun, K.-P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867.
39. Shinnick, T. M., R. A. Lerner, and J. G. Sutcliffe. 1981. Nucleotide sequence of Moloney murine leukemia virus. Nature (London) 293:543-548.
40. Shu, H. K., C. M. Chang, L. Ravi, L. Ling, C. M. Castellano, E. Walter, R. J. Pelley, and H. J. Kung. 1994. Modulation of erbB kinase activity and oncogenic potential by single point mutations in the glycine loop of the catalytic domain. Mol. Cell. Biol, 14:6868-6878.
41. Soman, N. R., P. Correa, B. A. Ruiz, and G. N. Wogan. 1991. The TRP-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc. Natl. Acad. Sci. USA 88:4892-4896.
42. Southern, E. M. 1975. Detection of specific sequence among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
43. Stitt, T. N., G. Conn, M. Gore, C. Lai, J. Bruno, C. Radziejewskl, K. Mattsson, J. Fisher, D. R. Gies, P. F. Jones, P. Masiakowski, T. E. Ryan, N. J. Tobkes, D. H. Chen, P. S. DiStefano, G. L. Long, C. Basilico, M. P. Goldfarb, G. Lemke, D. J. Glass, and G. D. Yancopoulos. 1995. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 80:661-670.
44. Taylor, I. C. A., S. Roy, P. Yaswen, M. R. Stampfer, and H. E. Varmus. 1995. Mouse mammary tumors express elevated levels of RNA encoding the murine homolog of SKY, a putative receptor tyrosine kinase. J. Biol. Chem. 270:6872-6880.
45. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
46. Van Beveren, C., S. Enami, T. Curran, and I. M. Verma. 1984. FBR murine osteosarcoma virus II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes. Virology 135: 229-243.
47. Varnum, B. C., C. Young, G. Elliott, A. Garcia, T. D. Bartley, Y. Fridell, R. W. Hunt, G. Trail, C. Clogston, R. J. Toso, D. Yanagihara, L. Bennett, M. Sylber, L. A. Merewether, A. Tseng, E. Escobar, E. T. Liu, and H. K. Yamane. 1995. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature (London) 373:623-626.
48. Vu, T. K., D. T. Hung, V. I. Wheaton, and S. Coughlin. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
49. Wang, L. H., B. Lin, S. M. Jong, D. Dixon, L. Ellis, R. A. Roth, and W. J. Rotter. 1987. Activation of transforming potential of the human insulin receptor gene. Proc. Natl. Acad. Sci. USA 84:5725-5729.
50. Watanabe, S. M., N. E. Rosenberg, and O. N. Witte. 1984. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro. J. Virol. 51:620-627.
51. Weiss, R., N. Teich, H. Varmus, and J. Coffin. 1982. RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
52. Wells, A., and M. Bishop. 1988. Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB. Proc. Natl. Acad. Sci. USA 85:7597-7601.